A 65-Year-Old Man Diagnosed with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

home / case-based-peer-perspectives / a-65-year-old-man-diagnosed-with-metastatic-hormone-sensitive-prostate-cancer

Dr Neal Shore shares his clinical perspectives and insights on the management of patients with mHSPC. With his extensive expertise, Dr Shore will delve into initial therapy considerations, emerging data on combination regimens, potential adverse events, and the future landscape of mHSPC treatment. This comprehensive overview will produce valuable insights for healthcare professionals seeking to optimize care for their patients with this challenging condition.